$AMRN
AMARIN CORP PLC\UK

2019 Q3 Form 10-Q Financial Statement

#000156459019040047 Filed on November 05, 2019

View on sec.gov

Income Statement

Concept 2019 Q3 2018 Q4 2018 Q3
Revenue $112.4M $77.33M $55.32M
YoY Change 103.18% 43.56% 16.81%
Cost Of Revenue $25.44M $17.51M $13.54M
YoY Change 87.9% 30.66% 13.79%
Gross Profit $86.96M $59.82M $41.78M
YoY Change 108.14% 48.07% 18.03%
Gross Profit Margin 77.36% 77.36% 75.52%
Selling, General & Admin $82.56M $79.69M $49.96M
YoY Change 65.25% 123.84% 50.48%
% of Gross Profit 94.93% 133.21% 119.57%
Research & Development $8.923M $11.91M $14.07M
YoY Change -36.59% 0.06% 31.51%
% of Gross Profit 10.26% 19.9% 33.68%
Depreciation & Amortization $208.0K $173.0K $166.0K
YoY Change 25.3% 1.76% -7.78%
% of Gross Profit 0.24% 0.29% 0.4%
Operating Expenses $91.48M $91.59M $64.03M
YoY Change 42.87% 92.42% 45.86%
Operating Profit -$4.518M -$31.77M -$22.25M
YoY Change -79.69% 341.28% 161.76%
Interest Expense $1.146M -$1.610M -$2.163M
YoY Change -152.98% -26.82% -9.88%
% of Operating Profit
Other Income/Expense, Net -$90.00K -$192.0K -$58.00K
YoY Change 55.17%
Pretax Income -$3.462M -$33.57M -$24.47M
YoY Change -85.85% 257.16% 126.58%
Income Tax $0.00 $96.00K $0.00
% Of Pretax Income
Net Earnings -$3.462M -$33.67M -$24.47M
YoY Change -85.85% 49.88% 126.06%
Net Earnings / Revenue -3.08% -43.54% -44.23%
Basic Earnings Per Share -$0.01 -$0.11 -$0.08
Diluted Earnings Per Share -$0.01 -$0.11 -$0.08
COMMON SHARES
Basic Shares Outstanding 351.0M 295.6M
Diluted Shares Outstanding 351.0M 295.6M

Balance Sheet

Concept 2019 Q3 2018 Q4 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $673.2M $249.2M $81.89M
YoY Change 722.07% 238.62% 3.53%
Cash & Equivalents $673.2M $249.2M $81.89M
Short-Term Investments
Other Short-Term Assets $16.76M $4.445M $3.535M
YoY Change 374.2% 8.41% -26.35%
Inventory $54.56M $57.80M $43.67M
Prepaid Expenses
Receivables $103.6M $66.52M $47.65M
Other Receivables $0.00 $0.00 $25.65M
Total Short-Term Assets $848.1M $378.0M $202.4M
YoY Change 319.02% 146.62% 37.69%
LONG-TERM ASSETS
Property, Plant & Equipment $2.124M $63.00K $69.00K
YoY Change 2978.26% 125.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.074M $174.0K $174.0K
YoY Change 517.24% 0.0% -98.46%
Total Long-Term Assets $18.84M $7.717M $7.885M
YoY Change 138.9% -7.34% -59.77%
TOTAL ASSETS
Total Short-Term Assets $848.1M $378.0M $202.4M
Total Long-Term Assets $18.84M $7.717M $7.885M
Total Assets $866.9M $385.7M $210.3M
YoY Change 312.26% 138.69% 26.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $42.04M $37.63M $26.17M
YoY Change 60.63% 49.6% 65.66%
Accrued Expenses $134.5M $84.17M $93.90M
YoY Change 43.28% 42.9% 81.97%
Deferred Revenue $1.962M $1.220M $1.220M
YoY Change 60.82% -25.79%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $51.17M $34.24M $30.13M
YoY Change 69.82% 53.21% 47.7%
Total Short-Term Liabilities $229.7M $157.3M $151.6M
YoY Change 51.48% 44.9% 68.3%
LONG-TERM LIABILITIES
Long-Term Debt $8.878M $46.11M $53.92M
YoY Change -83.54% -34.91% -48.4%
Other Long-Term Liabilities $5.402M $10.52M $8.652M
YoY Change -37.56% 815.04% -52.46%
Total Long-Term Liabilities $14.28M $56.63M $62.58M
YoY Change -77.18% -21.33% -49.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $229.7M $157.3M $151.6M
Total Long-Term Liabilities $14.28M $56.63M $62.58M
Total Liabilities $271.0M $233.4M $263.1M
YoY Change 3.01% 2.95% 23.7%
SHAREHOLDERS EQUITY
Retained Earnings -$1.418B -$1.389B -$1.355B
YoY Change 4.68% 9.17%
Common Stock $266.9M $246.7M $232.6M
YoY Change 14.71% -79.21%
Preferred Stock
YoY Change
Treasury Stock (at cost) $20.53M $10.41M $9.867M
YoY Change 108.1% 146.23%
Treasury Stock Shares $3.842M $3.261M $3.220M
Shareholders Equity $595.9M $152.3M -$52.83M
YoY Change
Total Liabilities & Shareholders Equity $866.9M $385.7M $210.3M
YoY Change 312.26% 138.69% 26.22%

Cashflow Statement

Concept 2019 Q3 2018 Q4 2018 Q3
OPERATING ACTIVITIES
Net Income -$3.462M -$33.67M -$24.47M
YoY Change -85.85% 49.88% 126.06%
Depreciation, Depletion And Amortization $208.0K $173.0K $166.0K
YoY Change 25.3% 1.76% -7.78%
Cash From Operating Activities $21.75M -$32.30M -$28.16M
YoY Change -177.24% 1409.49% 348.41%
INVESTING ACTIVITIES
Capital Expenditures -$1.313M $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities -$1.313M -$5.000K -$53.00K
YoY Change 2377.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 433.4M 200.5M 7.848M
YoY Change 5422.43% -6177.06% -7234.55%
NET CHANGE
Cash From Operating Activities 21.75M -32.30M -28.16M
Cash From Investing Activities -1.313M -5.000K -53.00K
Cash From Financing Activities 433.4M 200.5M 7.848M
Net Change In Cash 453.8M 168.2M -20.36M
YoY Change -2328.51% -3192.56% 218.7%
FREE CASH FLOW
Cash From Operating Activities $21.75M -$32.30M -$28.16M
Capital Expenditures -$1.313M $0.00 $0.00
Free Cash Flow $23.06M -$32.30M -$28.16M
YoY Change -181.9% 1409.49% 348.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019Q3 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2019Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
103583000
CY2019Q3 us-gaap Inventory Net
InventoryNet
54557000
CY2019Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12859000
CY2019Q3 us-gaap Assets Current
AssetsCurrent
848110000
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2124000
CY2019Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1074000
CY2019Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6996000
CY2019Q3 us-gaap Assets
Assets
866937000
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8633000
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019Q3 us-gaap Preferred Stock Shares Authorized Unlimited
PreferredStockSharesAuthorizedUnlimited
Unlimited
CY2018Q4 us-gaap Preferred Stock Shares Authorized Unlimited
PreferredStockSharesAuthorizedUnlimited
Unlimited
CY2018Q4 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2015Q1 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
0.1
us-gaap Revenue Practical Expedient Financing Component
RevenuePracticalExpedientFinancingComponent
true
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
174000
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7480000
CY2018Q4 us-gaap Assets
Assets
385714000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
37632000
CY2019Q3 amrn Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
134542000
CY2018Q4 amrn Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
84171000
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
34240000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
377997000
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2945000
dei Entity Shell Company
EntityShellCompany
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Address Address Line3
EntityAddressAddressLine3
Grand Canal Docklands
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2018Q4 us-gaap Inventory Net
InventoryNet
57802000
dei Entity Address City Or Town
EntityAddressCityOrTown
Dublin
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
2
dei Entity Address Country
EntityAddressCountry
IE
dei City Area Code
CityAreaCode
353 (0) 1
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
66523000
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
673207000
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
X0
dei Entity Address Address Line2
EntityAddressAddressLine2
Block C
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
249227000
dei Local Phone Number
LocalPhoneNumber
6699 020
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Address Address Line1
EntityAddressAddressLine1
77 Sir John Rogerson’s Quay
dei Entity File Number
EntityFileNumber
000-21392
dei Security12b Title
Security12bTitle
American Depositary Shares (ADS(s)), each ADSrepresenting the right to receive one (1) Ordinary Share of Amarin Corporation plc
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
63000
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Small Business
EntitySmallBusiness
false
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1500000
CY2019Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
3904000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
151884000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
65354000
CY2018Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
19490000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
37035000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
286478000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-82776000
us-gaap Net Income Loss
NetIncomeLoss
-82776000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
291526000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
291526000
CY2018Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1548000
CY2018Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-2553000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3754000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-24095000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
-16657000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-182000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29713000
us-gaap Gross Profit
GrossProfit
221124000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
147310000
us-gaap Operating Income Loss
OperatingIncomeLoss
-76454000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-134000
us-gaap Gross Profit
GrossProfit
114849000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
227598000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23295000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
43993000
us-gaap Operating Expenses
OperatingExpenses
250893000
us-gaap Operating Expenses
OperatingExpenses
191303000
us-gaap Operating Income Loss
OperatingIncomeLoss
-29769000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
238000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-6188000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
152330000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
246663000
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1282762000
CY2018Q4 us-gaap Treasury Stock Value
TreasuryStockValue
10413000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1388532000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
385714000
CY2018Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
13541000
CY2019Q3 us-gaap Gross Profit
GrossProfit
86964000
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
55323000
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
25444000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
112408000
CY2019Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
42042000
CY2019Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
51166000
CY2019Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1962000
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
229712000
CY2019Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
8878000
CY2019Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
17617000
CY2019Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5402000
CY2019Q3 us-gaap Liabilities
Liabilities
271041000
CY2019Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.05
CY2019Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
289317460
CY2019Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
289317460
CY2019Q3 amrn Preferred Stock Equivalent Ordinary Shares Upon Future Conversion Outstanding
PreferredStockEquivalentOrdinarySharesUponFutureConversionOutstanding
28931746
CY2019Q3 us-gaap Preferred Stock Value
PreferredStockValue
21850000
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.50
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
361368945
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
357527330
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
266878000
CY2019Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1745946000
CY2019Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
3841615
CY2019Q3 us-gaap Treasury Stock Value
TreasuryStockValue
20533000
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1418245000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
595896000
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
866937000
CY2018Q3 us-gaap Gross Profit
GrossProfit
41782000
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
82559000
CY2018Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
49960000
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14072000
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
91482000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4518000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-22250000
CY2019Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1146000
CY2018Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2163000
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-90000
CY2018Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-58000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3462000
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-24471000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-3462000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-24471000
us-gaap Net Income Loss
NetIncomeLoss
-29713000
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
350994000
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
295595000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
336938000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
350994000
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
295595000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
336938000
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1220000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
157263000
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
46108000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
10523000
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9432000
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
289317460
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
289317460
CY2018Q4 amrn Preferred Stock Equivalent Ordinary Shares Upon Future Conversion Outstanding
PreferredStockEquivalentOrdinarySharesUponFutureConversionOutstanding
28931746
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
21850000
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.50
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
329110863
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
325850013
CY2018Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
3260850
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8923000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
64032000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
152330000
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
15456000
CY2018Q4 us-gaap Liabilities
Liabilities
233384000
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.05
CY2019Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-9080000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6596000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-24431000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
140871000
CY2019Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
837000
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1888000
CY2019Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-1040000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8351000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-1820000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
149087000
CY2019Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
440108000
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2200000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7963000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-3462000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
595896000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-65100000
CY2018Q1 amrn Stockholders Equity Adjusted Balance
StockholdersEquityAdjustedBalance
-65318000
CY2018Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
70007000
CY2018Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
423000
CY2018Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
278000
CY2018Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-127000
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3606000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-34210000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
-46687000
CY2018Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
-39000
CY2018Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
14668000
CY2018Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-2958000
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6661000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-24471000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
-52826000
us-gaap Profit Loss
ProfitLoss
-29713000
us-gaap Profit Loss
ProfitLoss
-82776000
amrn Depreciation And Amortization Excluding Amortization Of Intangible Assets
DepreciationAndAmortizationExcludingAmortizationOfIntangibleAssets
53000
amrn Depreciation And Amortization Excluding Amortization Of Intangible Assets
DepreciationAndAmortizationExcludingAmortizationOfIntangibleAssets
12000
us-gaap Share Based Compensation
ShareBasedCompensation
22729000
us-gaap Share Based Compensation
ShareBasedCompensation
14032000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1282000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1687000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
484000
CY2019Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
103600000
CY2019Q3 us-gaap Inventory Net
InventoryNet
54600000
amrn Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-82776000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
291526000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.28
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
484000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
37060000
CY2019Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
14772000
CY2019Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
11909000
CY2019Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
28034000
CY2019Q3 us-gaap Inventory Gross
InventoryGross
54715000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-53000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2330000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
25654000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3245000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
13413000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
9914000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-520000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
900000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-145000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-371000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1131000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1902000
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
54962000
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
36005000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-4322000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
7502000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-430000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-62400000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2114000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
53000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2114000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
39000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
423000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
440945000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
70007000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
19544000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
16494000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
21441000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
10539000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
10120000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5638000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
428928000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
70708000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
426384000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8255000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
250727000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
74237000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
677111000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
82492000
us-gaap Interest Paid Net
InterestPaidNet
3577000
us-gaap Interest Paid Net
InterestPaidNet
16030000
us-gaap Income Taxes Paid
IncomeTaxesPaid
87000
us-gaap Income Taxes Paid
IncomeTaxesPaid
825000
amrn Initial Recognition Of Operating Lease Right Of Use Asset
InitialRecognitionOfOperatingLeaseRightOfUseAsset
8995000
amrn Number Of Patients Enrolled And Randomized In Study
NumberOfPatientsEnrolledAndRandomizedInStudy
8179
amrn Number Of Sales Professionals
NumberOfSalesProfessionals
400
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2019Q3 us-gaap Assets Current
AssetsCurrent
848100000
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
673200000
CY2019Q3 us-gaap Other Long Term Debt
OtherLongTermDebt
0
amrn Accounts Receivable Credit Period
AccountsReceivableCreditPeriod
P30D
CY2019Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
133531000
CY2018Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
86133000
CY2019Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
103583000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
66523000
CY2019Q3 amrn Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-3462000
CY2018Q3 amrn Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-24471000
amrn Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-29713000
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
350994000
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
295595000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
336938000
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:4.54%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Concentration of Credit Risk</span></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company maintains substantially all of its cash and cash equivalents in financial institutions believed to be of high-credit quality.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A significant portion of the Company’s sales are to wholesalers in the pharmaceutical industry. The Company monitors the creditworthiness of customers to whom it grants credit terms and has not experienced any credit losses. The Company does not require collateral or any other security to support credit sales. Three customers individually accounted for 10% or more of the Company’s gross product sales. Customers A, B, and C accounted for 25%, 36%, and 29%, respectively, of gross product sales for the nine months ended September 30, 2019, and represented 42%, 23%, and 28%, respectively, of the gross accounts receivable balance as of September 30, 2019. Customers A, B, and C accounted for 26%, 31%, and 31%, respectively, of gross product sales for the nine months ended September 30, 2018 and represented 37%, 33%, and 17%, respectively, of the gross accounts receivable balance as of September 30, 2018. The Company has not experienced any significant write-offs of its accounts receivable.</p>
CY2019Q3 amrn Long Term Debt Current Net Of Accrued Interest
LongTermDebtCurrentNetOfAccruedInterest
50672000
CY2018Q4 amrn Long Term Debt Current Net Of Accrued Interest
LongTermDebtCurrentNetOfAccruedInterest
33602000
CY2019Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
8878000
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
46108000
CY2019Q3 us-gaap Long Term Debt
LongTermDebt
59550000
CY2018Q4 us-gaap Long Term Debt
LongTermDebt
79710000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P10Y9M18D
CY2019Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
11624000
CY2018Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
11624000
CY2019Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4628000
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4144000
CY2019Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6996000
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7480000
CY2018Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
14142000
CY2018Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
8590000
CY2018Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
35357000
CY2018Q4 us-gaap Inventory Gross
InventoryGross
58089000
CY2019Q3 us-gaap Inventory Adjustments
InventoryAdjustments
158000
CY2018Q4 us-gaap Inventory Adjustments
InventoryAdjustments
287000
CY2019Q3 us-gaap Inventory Net
InventoryNet
54557000
CY2018Q4 us-gaap Inventory Net
InventoryNet
57802000
CY2019Q3 us-gaap Purchase Obligation
PurchaseObligation
90000000.0
CY2015Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.05
CY2015Q1 amrn Private Placement Closing Date
PrivatePlacementClosingDate
2015-03-30
CY2015Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
52800000
CY2015Q1 amrn Equity Offering Costs
EquityOfferingCosts
700000
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.50
CY2015Q1 us-gaap Share Price
SharePrice
2.39
CY2015Q2 us-gaap Preferred Stock Conversions Inducements
PreferredStockConversionsInducements
31300000
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
16259328
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
5122107
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
5439239
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
19500000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
16500000
CY2019Q3 amrn Cash Discount Percent
CashDiscountPercent
0.02
CY2018Q4 amrn Valuation Allowances Provisions And Reserves Balance Net
ValuationAllowancesProvisionsAndReservesBalanceNet
65244000
us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
369133000
amrn Provision Related To Prior Period Sales
ProvisionRelatedToPriorPeriodSales
204000
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
249600000
amrn Credits Payments Made For Prior Period Sales
CreditsPaymentsMadeForPriorPeriodSales
62540000
CY2019Q3 amrn Valuation Allowances Provisions And Reserves Balance Net
ValuationAllowancesProvisionsAndReservesBalanceNet
122033000
CY2017Q4 amrn Valuation Allowances Provisions And Reserves Balance Net
ValuationAllowancesProvisionsAndReservesBalanceNet
48093000
us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
175167000
amrn Provision Related To Prior Period Sales
ProvisionRelatedToPriorPeriodSales
1565000
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
106961000
amrn Credits Payments Made For Prior Period Sales
CreditsPaymentsMadeForPriorPeriodSales
43617000
CY2018Q3 amrn Valuation Allowances Provisions And Reserves Balance Net
ValuationAllowancesProvisionsAndReservesBalanceNet
71117000
CY2018Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
20710000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1131000
CY2019Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
19579000
CY2017Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
19054000
amrn Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
2500000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
598000
CY2018Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
20956000
amrn Contract With Customer Liability Revenue Recognized Excluding Performance Obligation Satisfied In Previous Period
ContractWithCustomerLiabilityRevenueRecognizedExcludingPerformanceObligationSatisfiedInPreviousPeriod
1131000
amrn Contract With Customer Liability Revenue Recognized Excluding Performance Obligation Satisfied In Previous Period
ContractWithCustomerLiabilityRevenueRecognizedExcludingPerformanceObligationSatisfiedInPreviousPeriod
405000
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
193000
CY2019Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.115
amrn Operating Lease Change In Weighted Average Discount Rate Percent
OperatingLeaseChangeInWeightedAverageDiscountRatePercent
0.01
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
9600000
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8600000
CY2019Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
400000
us-gaap Operating Lease Expense
OperatingLeaseExpense
1100000
CY2019Q3 us-gaap Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year
PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear
124000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1344000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1743000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1801000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1835000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
11376000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
18223000
CY2019Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
8667000
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
9556000

Files In Submission

Name View Source Status
0001564590-19-040047-index-headers.html Edgar Link pending
0001564590-19-040047-index.html Edgar Link pending
0001564590-19-040047.txt Edgar Link pending
0001564590-19-040047-xbrl.zip Edgar Link pending
amrn-10q_20190930.htm Edgar Link pending
amrn-10q_20190930_htm.xml Edgar Link completed
amrn-20190930.xsd Edgar Link pending
amrn-20190930_cal.xml Edgar Link unprocessable
amrn-20190930_def.xml Edgar Link unprocessable
amrn-20190930_lab.xml Edgar Link unprocessable
amrn-20190930_pre.xml Edgar Link unprocessable
amrn-ex311_6.htm Edgar Link pending
amrn-ex312_7.htm Edgar Link pending
amrn-ex321_12.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending